TY - CONF T1 - LONG-TERM EFFICACY AND SAFETY OF DUPILUMAB IN A PHASE 3 OPEN-LABEL EXTENSION TRIAL (LIBERTY AD PED-OLE) IN PATIENTS AGED >= 6 TO < 12 YEARS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS JO - ACTA DERMATO-VENEREOLOGICA PY - 2021/01/01 AU - Cork MJ AU - Thaci D AU - Eichenfield LF AU - Arkwright PD AU - Chen Z AU - Prescilla R AU - Delevry D AU - O'Malley JT AU - Bansal A ED - VL - 101 SP - 60 EP - 60 Y2 - 2025/07/17 ER -